Moreover, a recent study conducted on mice shown that valacyclovir effectively targeted crucial pathogenic components of AD, including neuroinflammation, β-amyloid protein levels, and cholinesterase function [52]. This evidence concerns the gene BCHE and Alzheimer disease.